Jon Saxe

Jon Saxe

Net worth: 1 171 $ as of 2026-05-30

89 year
Health Technology
Commercial Services
Consumer Services

Profile

Jon Sheldon Saxe currently works at Vistagen Therapeutics, Inc., as Independent Chairman from 2026, Vytacera Pharma, Inc., as Chairman, Epalex Corp., as Chairman from 2017, and various other companies.
Mr. Saxe also formerly worked at Synergen, Inc., as President, Chief Executive Officer & Director from 1989 to 1993, SciClone Pharmaceuticals LLC, as Chairman from 2009 to 2017, POINT Biomedical Corp., as Chairman, and various other companies.
Mr. Saxe received his undergraduate degree from Carnegie Mellon University, graduate degree from George Washington University Law School, and graduate degree from New York University School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-09-08 1,858 ( 0% ) 1 171 $ 2026-05-30

Jon Saxe active positions

CompaniesPositionStart
VISTAGEN THERAPEUTICS, INC. Chairman 2000-05-31
CANCER PREVENTION PHARMACEUTICALS INC Director/Board Member 2015-07-22
K2X TECHNOLOGY & LIFE SCIENCE, INC. Director/Board Member 2021-01-07
Vytacera Pharma, Inc.
Chairman -
Director/Board Member 2016-05-31
Director/Board Member 2019-10-31
Aether, Inc.
Director/Board Member 2020-02-29
Chairman 2017-07-31
Director/Board Member 2011-06-24
░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░

Former positions of Jon Saxe

CompaniesPositionEnd
░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Jon Saxe's experience

Training of Jon Saxe

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

42

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies42

Health Technology

Health Technology

Health Technology

Health Technology

Utilities

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Technology Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Saxe Associates, Inc.

Health Technology

Health Technology

Health Technology

VistaGen, Inc.

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Consumer Services

Consumer Services

Vytacera Pharma, Inc.

Commercial Services

Commercial Services

Sciele Pharmaceuticals, Inc.

Aether, Inc.

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!